Evaluation of Pancreatic Tissue Penetration of Meronem® in the Prophylaxis of Septic Complications in Severe Pancreatitis
NCT00318994
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
6
Enrollment
INDUSTRY
Sponsor class
Conditions
Pancreatitis
Interventions
DRUG:
Meropenem
Sponsor
Pfizer